Standards; Pharmaceutical/API Drug Impurities/Metabolites;
应用:
Hydroxymethyl Ruxolitinib is an impurity of Ruxolitinib. Ruxolitinib is a selective Janus tyrosine kinase (JAK1 and JAK2) inhibitor used in the treatment of myeloproliferative neoplasms and psoriasis.